Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2003

View Archived Issues

SYM-2081 attenuates inflammatory hyperalgesia

KRN-5500 shows significant activity against CLL cells in vitro

VEGF Trap prevents blinding blood vessel growth in mice

Ghrelin could have therapeutic value in endotoxic shock

Reductions in NK-kappaB activation may improve the outcome for sepsis

Sepracor reports phase III Estorra data in elderly patients

Enbrel approved for inhibition of bone and joint damage in psoriatic arthritis patients

Estrogen receptor agonist as a potential new treatment for hot flush

Oxymorphazole: a potent antinociceptive agent in mice

LY-503430: a new neuroprotective agent with therapeutic potential in Parkinson's disease

Two series of rifamycin antibiotics patented by ActivBiotics scientists

Novel imaging agents for the diagnosis of AD developed at Amersham

New anti-herpesvirus DNA polymerase agents identified at Pharmacia

Guilford presents new DPP-IV inhibitors for Parkinson's disease and other neurological disorders

South African approval to begin phase I trial of HIVA.MVA

Phase IIa DB-289 malaria study completes first stage

EpiPen approved in Japan for anaphylaxis triggered by insect stings

Long-lasting tumor responses seen in phase II NHL study of pixantrone

NIH program to evaluate Maxheal for SARS

Health Canada accepts Bexxar under priority review

APF-112 set to enter phase II postsurgical pain relief study in September

RealArt HPA Coronavirus test CE marked

Leptin exerts cardiac antihypertrophic effects in mice independent of weight loss

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...